BASOLO, FULVIO
 Distribuzione geografica
Continente #
NA - Nord America 31.306
EU - Europa 13.334
AS - Asia 13.206
SA - Sud America 2.458
AF - Africa 751
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 15
Totale 61.092
Nazione #
US - Stati Uniti d'America 30.486
CN - Cina 4.171
IT - Italia 4.036
SG - Singapore 3.133
HK - Hong Kong 2.868
SE - Svezia 2.487
DE - Germania 2.178
BR - Brasile 2.113
BG - Bulgaria 1.103
GB - Regno Unito 874
TR - Turchia 815
VN - Vietnam 772
CA - Canada 642
RU - Federazione Russa 531
FI - Finlandia 487
AT - Austria 449
UA - Ucraina 389
CI - Costa d'Avorio 322
KR - Corea 312
IN - India 298
FR - Francia 198
JP - Giappone 158
SN - Senegal 150
CH - Svizzera 135
BD - Bangladesh 122
AR - Argentina 117
NL - Olanda 111
IQ - Iraq 93
BE - Belgio 86
PK - Pakistan 67
MX - Messico 61
ID - Indonesia 59
EC - Ecuador 57
ZA - Sudafrica 55
SA - Arabia Saudita 54
PL - Polonia 53
MA - Marocco 50
VE - Venezuela 47
NG - Nigeria 46
ES - Italia 43
UZ - Uzbekistan 40
CO - Colombia 39
JO - Giordania 31
LT - Lituania 24
EG - Egitto 23
IR - Iran 23
KE - Kenya 22
PY - Paraguay 22
IL - Israele 20
UY - Uruguay 20
AU - Australia 19
AZ - Azerbaigian 18
PA - Panama 18
PE - Perù 18
CZ - Repubblica Ceca 17
RO - Romania 17
BJ - Benin 16
JM - Giamaica 16
AL - Albania 15
GR - Grecia 15
MY - Malesia 15
NP - Nepal 15
TN - Tunisia 15
EU - Europa 14
IE - Irlanda 14
TT - Trinidad e Tobago 13
CL - Cile 12
DO - Repubblica Dominicana 12
PT - Portogallo 11
TW - Taiwan 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
DZ - Algeria 10
PH - Filippine 10
RS - Serbia 10
ET - Etiopia 9
HN - Honduras 9
HU - Ungheria 9
KZ - Kazakistan 9
OM - Oman 9
PS - Palestinian Territory 9
BO - Bolivia 8
EE - Estonia 8
LB - Libano 8
BY - Bielorussia 7
NI - Nicaragua 7
BN - Brunei Darussalam 6
GA - Gabon 6
KG - Kirghizistan 6
BB - Barbados 5
BH - Bahrain 5
DK - Danimarca 5
LK - Sri Lanka 5
AM - Armenia 4
AO - Angola 4
CY - Cipro 4
GD - Grenada 4
GT - Guatemala 4
KH - Cambogia 4
KW - Kuwait 4
Totale 61.001
Città #
Ashburn 3.441
Fairfield 3.028
Hong Kong 2.742
Woodbridge 2.475
Chandler 2.180
Dallas 2.175
Houston 1.807
Ann Arbor 1.627
Santa Clara 1.610
Singapore 1.464
Seattle 1.279
Wilmington 1.120
Sofia 1.099
Cambridge 1.009
Shanghai 1.001
Beijing 952
New York 762
Milan 687
Ottawa 523
Izmir 511
Boardman 504
Serra 504
Princeton 486
Lawrence 443
Jacksonville 438
Los Angeles 405
Medford 393
Vienna 393
Hefei 374
Abidjan 321
Nanjing 317
Seoul 296
Des Moines 257
Florence 249
Pisa 245
Munich 230
London 213
Istanbul 204
San Diego 199
Dearborn 189
Buffalo 179
Frankfurt am Main 178
São Paulo 178
Columbus 176
The Dalles 172
Redondo Beach 163
Dakar 150
Rome 150
Dong Ket 147
Ho Chi Minh City 127
Tokyo 124
Council Bluffs 121
Nanchang 119
Bern 115
Bremen 114
Boulder 93
Falls Church 91
Kunming 90
Ogden 90
Hanoi 85
Brussels 81
Turku 80
Chicago 74
Rio de Janeiro 74
Lancaster 69
Shenyang 69
Jüchen 68
Changsha 66
Redwood City 63
Naples 61
Hebei 54
Belo Horizonte 52
Washington 52
Düsseldorf 51
Pune 51
Bologna 47
Fuzhou 47
Nürnberg 46
Tianjin 46
Norwalk 45
Helsinki 42
Jiaxing 41
Brasília 40
Cascina 40
Guangzhou 40
Lagos 40
Toronto 40
San Francisco 39
Tashkent 38
Quanzhou 37
Baghdad 36
Hangzhou 36
Jinan 36
Lucca 36
Nuremberg 35
Warsaw 34
Phoenix 33
Redmond 33
Zhengzhou 33
Porto Alegre 32
Totale 42.751
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.079
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 320
null 259
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES 240
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 237
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 235
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 232
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10 years follow up study 229
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 227
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 227
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 220
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 218
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 213
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 213
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 211
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 208
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 204
Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center 203
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 203
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 202
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 202
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 202
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 201
Picornavirus-induced immuno-suppression 200
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 199
Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules 197
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 196
Molecular testing in the diagnosis of differentiated thyroid carcinomas 195
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 194
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 192
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 191
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 188
A proteomic approach to study parathyroid glands 186
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 184
Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report 184
Surgical treatment of pleural recurrence from thymoma 183
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 182
A pandemic recap: lessons we have learned 182
MULTIPLE ORGAN-REACTIVITY OF MONOCLONAL AUTOANTIBODIES TO MOUSE ERYTHROCYTES 181
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 181
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 181
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 180
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 180
PRODUCTIVE HIV-1 INFECTION OF NORMAL HUMAN MAMMARY EPITHELIAL-CELLS 179
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 177
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 177
DIABETES MELLITUS 176
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes 175
Prevalence of papillary thyroid cancer (PTC) in patients affected by medullary thyroid cancer (MTC) 173
FR-MLV INFECTION INDUCES ERYTHROLEUKEMIA INSTEAD OF LYMPHOID LEUKEMIA IN MICE GIVEN PITUITARY GRAFTS 172
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 172
KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) 172
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 172
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 172
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 171
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer 170
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 168
SYSTEMIC LYMPHOID ATROPHY IN COXSACKIE-VIRUS B3-INFECTED MICE - EFFECTS OF VIRUS AND IMMUNOPOTENTIATING AGENTS 167
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 167
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 167
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 166
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 166
MATRIGEL PROMOTES RETINOBLASTOMA CELL-GROWTH INVITRO AND INVIVO 165
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 165
Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes 165
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 164
Influence of T and N stages on long term survival in resectable small cell lung cancer 163
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 163
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 163
Lipomatous hamartoma-like lesion of a bicuspid aortic valve: an incidental surgical finding 163
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients 162
Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations 162
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 162
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 162
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 162
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 162
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 161
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 161
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 161
Ectopic expression of bone sialoprotein in human thyroid cancer 160
null 160
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 160
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 160
miR-19a and miR-20a and tissue factor expression in activated human peripheral blood mononuclear cells 160
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 159
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 159
ADJUVANT CHEMOTHERAPY FOR T1-2NOMO SMALL-CELL LUNG-CANCER - SINGLE-AGENT OR COMBINATION CHEMOTHERAPY 157
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 157
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 157
Prevalence of Thyroid Cancer in Multinodular Goiter Versus Single Nodule: Iodine Intake and Cancer Phenotypes. 157
null 157
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 157
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 157
Plasma and tissue chromogranin in patients with adrenocortical adenomas 156
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 156
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine 155
Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology 155
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 155
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 155
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 155
Totale 19.070
Categoria #
all - tutte 182.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.691 0 0 0 0 370 189 294 386 354 317 234 547
2021/20225.364 124 221 151 396 995 831 163 236 282 264 293 1.408
2022/20237.108 893 961 516 643 756 890 100 574 1.197 64 435 79
2023/20244.464 476 417 482 358 635 838 191 156 145 116 175 475
2024/202515.066 124 572 153 907 1.452 1.493 1.216 855 1.586 1.888 1.591 3.229
2025/20267.605 1.085 2.210 2.218 1.410 682 0 0 0 0 0 0 0
Totale 61.984